Literature DB >> 9850057

A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription.

J L Rutter1, T I Mitchell, G Butticè, J Meyers, J F Gusella, L J Ozelius, C E Brinckerhoff.   

Abstract

Matrix metalloproteinases (MMPs) facilitate cellular invasion by degrading the extracellular matrix, and their regulation is partially dependent on transcription. Binding sites for members of the Ets family of transcription factors are present within MMP promoters and are potent positive regulators. We report a single nucleotide polymorphism at -1607 bp in the MMP-1 promoter, where an additional guanine (G) creates an Ets binding site, 5'-GGA-3'. This polymorphism displays significantly higher transcription in normal fibroblasts and in melanoma cells than the 1 G polymorphism, and it binds substantially more nuclear extract and recombinant ETS-1. Analysis of control DNAs from the Center d'Etude du Polymorphisme Humain pedigrees reveals that this polymorphism is not a mutation, with a frequency of the 2 G polymorphism at 30%. In contrast, in eight tumor cell lines, this frequency increased to 62.5% (P < 0.0001). Thus, this MMP-1 polymorphism contributes to increased transcription, and cells expressing the 2 G polymorphism may provide a mechanism for more aggressive matrix degradation, thereby facilitating cancer progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850057

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  150 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  MMPs in tuberculosis: granuloma creators and tissue destroyers.

Authors:  Padmini Salgame
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

3.  Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors.

Authors:  Jing Zhou; Constance Brinckerhoff; Susan Lubert; Kui Yang; Jasmine Saini; Jeffrey Hooke; Richard Mural; Craig Shriver; Stella Somiari
Journal:  Cancer Invest       Date:  2011-11       Impact factor: 2.176

4.  Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.

Authors:  Marni Stott-Miller; John R Houck; Pawadee Lohavanichbutr; Eduardo Méndez; Melissa P Upton; Neal D Futran; Stephen M Schwartz; Chu Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

Review 5.  Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis.

Authors:  C Zhang; L Chen; Y Gu
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

6.  An expectation-maximization algorithm for the analysis of allelic expression imbalance.

Authors:  M D Teare; J Heighway; M F Santibáñez Koref
Journal:  Am J Hum Genet       Date:  2006-06-30       Impact factor: 11.025

Review 7.  MMPs as therapeutic targets--still a viable option?

Authors:  Barbara Fingleton
Journal:  Semin Cell Dev Biol       Date:  2007-07-06       Impact factor: 7.727

8.  Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan.

Authors:  Mei-Due Yang; Kuo-Cheng Lin; Meng-Chun Lu; Long-Bin Jeng; Chieh-Lun Hsiao; Te-Cheng Yueh; Chun-Kai Fu; Hsin-Ting Li; Shiou-Ting Yen; Chia-Wen Lin; Cin-Wun Wu; Su-Yi Pang; Da-Tian Bau; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2017-06-14

9.  Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China.

Authors:  Yan Li; Dong-lan Sun; Ya-nan Duan; Xiao-juan Zhang; Na Wang; Rong-miao Zhou; Zhi-feng Chen; Shi-jie Wang
Journal:  Mol Biol Rep       Date:  2009-06-28       Impact factor: 2.316

10.  MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis.

Authors:  Marco Checa; Víctor Ruiz; Martha Montaño; Rafael Velázquez-Cruz; Moisés Selman; Annie Pardo
Journal:  Hum Genet       Date:  2008-10-14       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.